脑电图表现可为与静脉-动脉体外生命支持期间死亡相关的临床特征增加预后价值
这是一项回顾性单中心研究,纳入2015年1月1日至2020年9月30日接受静脉-动脉ECMO并完成连续脑电图监测的94例儿科患者,住院死亡率为43%。非存活者ECMO启动前pH显著更低、乳酸水平更高;20%出现癫痫发作,7%发展为癫痫持续状态;ECMO运行前24小时内不良背景评分及缺乏cEEG变异或反应性与死亡相关。含ECMO启动前2小时pH与乳酸、脑电发作、cEEG不对称性的多变量模型AUROC为0.8(95%CI 0.74-0.86,p<0.02),含ECMO启动前2小时pH、脑电发作及任一时刻缺乏变异/反应性的模型AUROC为0.85(95%CI 0.8-0.9,p<0.001)。作者认为这些数据提示ECMO启动时机与组织氧合恶化关系需进一步研究,cEEG可能用于评估神经损伤和死亡风险。
要点
- 94例接受静脉-动脉ECMO并cEEG监测的儿科患者中,住院死亡率为43%。
- 非存活者ECMO启动前pH显著更低、乳酸水平显著更高。
- 19例(20%)出现癫痫发作,7例(7%)发展为癫痫持续状态。
- ECMO运行前24小时内,不良背景评分及缺乏cEEG变异或反应性与死亡相关。
- 含ECMO启动前2小时pH、乳酸、脑电发作及cEEG不对称性的多变量模型AUROC为0.8(95%CI 0.74-0.86,p<0.02);含ECMO启动前2小时pH、脑电发作及任一时刻缺乏变异/反应性的模型AUROC为0.85(95%CI 0.8-0.9,p<0.001)。
适用人群与场景
- 2015年1月1日至2020年9月30日在一家中心接受静脉-动脉ECMO并完成连续脑电图监测的儿科患者,共94例。
研究设计与关键结果
- 回顾性单中心研究,纳入94例接受静脉-动脉ECMO并cEEG监测的儿科患者,住院死亡率为43%。
- 非存活者ECMO启动前pH显著更低、乳酸水平显著更高。
- 19例(20%)出现癫痫发作,其中7例(7%)发展为癫痫持续状态。
- ECMO运行前24小时内,不良背景评分及缺乏cEEG变异或反应性与死亡相关。
- 含ECMO启动前2小时pH与乳酸、脑电发作、cEEG不对称性的多变量模型预测住院死亡,AUROC为0.8(95%CI 0.74-0.86,p<0.02)。
- 含ECMO启动前2小时pH、脑电发作及任一时刻缺乏变异/反应性的多变量模型预测ECMO期间死亡,AUROC为0.85(95%CI 0.8-0.9,p<0.001)。
证据类型、等级与局限
- 证据类型:回顾性单中心研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,这些数据提示ECMO启动时机与组织氧合恶化的关系应进一步研究。
- 作者认为,cEEG可能用于评估神经损伤和死亡风险的潜在影响。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The objective of this study was to identify clinical and continuous electroencephalogram (cEEG) variables associated with outcomes of pediatric venoarterial (V-A) extracorporeal membrane oxygenation support (ECMO).
METHODS: We conducted a retrospective single-center study of pediatric patients on V-A ECMO between January 1, 2015, and September 30, 2020. Serial clinical and cEEG variables were collected to assess the relationship of pre- and on-ECMO variables with hospital mortality in patients who underwent cEEG monitoring.
RESULTS: Ninety-four patients undergoing V-A ECMO had cEEG monitoring, with a hospital mortality of 43%. Nonsurvivors had significantly lower pH and higher lactate levels prior to ECMO initiation. Nineteen (20%) had seizures, with 7 (7%) developing status epilepticus. In the first 24 h patients were on ECMO, unfavorable background score and lack of cEEG variability or reactivity were associated with mortality. A multivariable model investigating in-hospital mortality that included pH and lactate level 2 h prior to ECMO initiation, presence of electrographic seizures, and asymmetry on cEEG as variables, had an area under the receiver operating characteristic curve (AUROC) of 0.8 (95% confidence interval [CI] 0.74-0.86, p < 0.02). The model for on-ECMO mortality (ECMO nonsurvivors) that included pH 2 h prior to ECMO initiation, presence of electrographic seizures, and lack of variability/reactivity at any point on cEEG as variables had an AUROC of 0.85 (95% CI 0.8-0.9, p < 0.001).
CONCLUSIONS: These data demonstrate an association of evolving pre-ECMO impaired tissue oxygenation and on-ECMO neurophysiologic impairment, measured by cEEG, with mortality. They provide preliminary evidence that the timing of ECMO initiation, in relation to worsening tissue oxygenation, should be investigated further, and cEEG may be used to evaluate the potential impact on both neurologic injury and mortality.
参考来源
- Baker A, Shah E, Ouyang A, et al. Electroencephalographic Findings Add Prognostic Value to Clinical Features Associated with Mortality on Venoarterial Extracorporeal Support. Neurocrit Care. 2025. PMID: 40244546. doi:10.1007/s12028-025-02248-7
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。